Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Five Prime Therapeutics announced UCB has elected to exclusively license an undisclosed drug target for inflammatory diseases. Five Prime identified the target using its discovery platform.
read more
Hovione reported recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey, with the aim to increase capacity in existing technologies
read more
LabCorp announced its Covance Drug Development business has formed a global immunology and immunotoxicology unit dedicated to the specific needs of biologic drug development.
read more
BiondVax developer of the Universal Flu Vaccine candidate M-001, announced the signing of a MSA with a CRO to conduct the first pivotal, clinical efficacy, Phase 3 trial of M-001.
read more
Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm.
read more
Ardena has acquired ChemConnection, a contract manufacturer of novel APIs and nanomedicines.
read more
Wednesday, March 14, 2018
Crown Bioscience has been selected by Phanes Therapeutics as a strategic partner to advance their oncology drug discovery pipeline.
read more
Wednesday, March 14, 2018
Nanologica AB has entered into a service agreement with global CDMO Sterling Pharma Solutions for the large-scale production of silica particles.
read more
Wednesday, March 14, 2018
Minakem has initiated the extension of its manufacturing capacity at its Dunkirk site in France.
read more
Wednesday, March 14, 2018
Recipharm announces its new blow-fill-seal machinery is now operational following an investment last year at its facility in Kaysersberg, France.
read more
Intec Pharma has partnered with LTS for the manufacture of the Accordion Pill Carbidopa/Levodopa as a treatment for Parkinson's Disease symptoms.
read more
Waverley Pharma announced its wholly-owned Irish Subsidiary has submitted a Marketing Authorization application through the European Union's De-Centralized Procedure for an anti-cancer generic drug.
read more
PAREXEL announced an alliance with CHA Medical Group (CHA) to enhance early phase clinical development in Korea.
read more
SanBio Group and Hitachi Chemical jointly announced that they will manufacture SB623, a proprietary regenerative medicine product under development by SanBio.
read more
Lannett has entered into separate agreements with three strategic alliance partners.
read more